First, while our findings are validated in preclinical models and TCGA-KIRC datasets, further confirmation in larger, multi-center clinical cohorts is needed to establish COP1’s prognostic relevance across RCC subtypes. This evidence concerns the gene COP1 and renal cell carcinoma.